Correlation Between ZyVersa Therapeutics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Conduit Pharmaceuticals, you can compare the effects of market volatilities on ZyVersa Therapeutics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Conduit Pharmaceuticals.
Diversification Opportunities for ZyVersa Therapeutics and Conduit Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ZyVersa and Conduit is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Conduit Pharmaceuticals
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 0.79 times more return on investment than Conduit Pharmaceuticals. However, ZyVersa Therapeutics is 1.27 times less risky than Conduit Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 22.00 in ZyVersa Therapeutics on July 27, 2025 and sell it today you would lose (8.00) from holding ZyVersa Therapeutics or give up 36.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Conduit Pharmaceuticals |
ZyVersa Therapeutics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Conduit Pharmaceuticals
The main advantage of trading using opposite ZyVersa Therapeutics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| ZyVersa Therapeutics vs. Aditxt Inc | ZyVersa Therapeutics vs. Scinai Immunotherapeutics | ZyVersa Therapeutics vs. Longevity Health Holdings, | ZyVersa Therapeutics vs. Celularity |
| Conduit Pharmaceuticals vs. Zivo Bioscience | Conduit Pharmaceuticals vs. Aditxt Inc | Conduit Pharmaceuticals vs. Aspire BioPharma, | Conduit Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |